Portal infusion of a selective serotonin reuptake inhibitor enhances hepatic glucose disposal in conscious dogs

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 6 50-6, 2004, Pages

  Moore, Mary Courtney ^a   DiCostanzo, Catherine A ^a   Dardevet, Dominique ^a   Lautz, Margaret ^a   Farmer, Ben ^a   Neal, Doss W ^a   Cherrington, Alan D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glycemia; Hepatic glucose uptake; Liver; Nonhepatic glucose uptake; Portal vein

Indexed keywords

CARBON; CATECHOLAMINE; FLUVOXAMINE; GLUCAGON; GLUCOSE; GLUCOSE H 3; INSULIN; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE; SOMATOSTATIN; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD; CARBON STORAGE; CONSCIOUSNESS; DIET RESTRICTION; DOG; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYPOTHESIS; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL;

ANIMALS; CARBON; DOGS; FATTY ACIDS, NONESTERIFIED; FEMALE; FLUVOXAMINE; GLUCOSE; GLYCEROL; GLYCOGEN; HORMONES; LACTIC ACID; LIVER; MALE; OSMOLAR CONCENTRATION; PORTAL VEIN; SEROTONIN UPTAKE INHIBITORS;

EID: 8544238506     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00313.2004     Document Type: Article

References (38)

1. Adkins BA, Myers SR, Hendrick GK, Stevenson RW, Williams PE, and Cherrington AD. Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog. J Clin Invest 79: 557-565, 1987.
2. Ahren B, Dunning BE, Havel PJ, Veith RC, and Taborsky GJ Jr. Extraction of epinephrine and norepinephrine by the dog pancreas in vivo. Metabolism 37: 68-73, 1988.
3. Anthony M. Serotonin antagonists. Aust NZ J Med 14: 888-895, 1984.
4. Bearcroft CP, Perrett D, and Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 42: 42-46, 1998.
5. Blombery PA and Heinzow BG. Cardiac and pulmonary norepinephrine release and removal in the dog. Circ Res 53: 688-694, 1983.
6. 2C receptors. Br J Pharmacol 115: 662-628, 1995.
7. Chu CA, Sindelar DK, Neal DW, Allen EJ, Donahue EP, and Cherrington AD. Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. J Clin Invest 99: 1044-1056, 1997.
8. Clerk LH, Smith ME, Rattigan S, and Clark MG. Nonnutritive flow impairs uptake of fatty acid by white muscles of the perfused rat hindlimb. Am J Physiol Endocrinol Metab 284: E611-E617, 2003.
9. Cowan JS and Hetenyi G Jr. Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method. Metabolism 20: 360-372, 1971.
10. Endo Y. Evidence that the accumulation of 5-hydroxytryptamine in the liver but not in the brain may cause the hypoglycaemia induced by 5-hydroxytryptophan. Br J Pharmacol 85: 591-598, 1985.
11. Erenmemisoglu A, Ozdogan UK, Saraymen R, and Tutus A. Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice. J Pharm Pharmacol 51: 741-743, 1999.
12. Geho WB and Lau JR. Hepatocyte Directed Vesicle Delivery System. US Patent No. 4,603,044. In: U.S. Patent Office. USA: Technology Unlimited, 1986.
13. Goldstein RE, Reed GW, Wasserman DH, Williams PE, Lacy DB, Buckspan R, Abumrad NN, and Cherrington AD. The effects of acute elevations in plasma cortisol levels on alanine metabolism in the conscious dog. Metabolism 41: 1295-1303, 1992.
14. Hajduch E, Rencurel F, Balendran A, Batty IH, Downes CP, and Hundal HS. Serotonin (5-hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle. J Biol Chem 274: 13563-13568, 1999.
15. Hendrick GK, Frizzell RT, Williams PE, and Cherrington AD. Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast. Am J Physiol Endocrinol Metab 258: E841-E849, 1990.
16. Hiemke C and Hartter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 85: 11-28, 2000.
17. Hsieh PS, Moore MC, Neal DW, Emshwiller M, and Cherrington AD. Rapid reversal of the effects of the portal signal under hyperinsulinemic conditions in the conscious dog. Am J Physiol Endocrinol Metab 276: E930-E937, 1999.
18. Hsieh PS, Moore MC, Neal DW, Venson P, and Cherrington AD. Hepatic glucose uptake rapidly decreases after elimination of the portal signal in conscious dogs. Am J Physiol Endocrinol Metab 275: E987-E992, 1998.
19. Jackson RA, Hamling JB, Sim BM, Hawa MI, Blix PM, and Nabarro JD. Peripheral lactate and oxygen metabolism in man: the influence of oral glucose loading. Metabolism 36: 144-150, 1987.
20. Jackson RA, Roshania RD, Hawa MI, Sim BM, and DiSilvio L. Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: an analysis based on simultaneous use of the forearm and double isotope techniques. J Clin Endocrinol Metab 63: 541-549, 1986.
21. Keppler D and Decker K. Glycogen: determination with amyloglucosidase. In: Methods in Enzymatic Analysis, edited by Bergmeyer HU. New York: Verlag Chemie Weinheim/Academic, 1974, p. 1127-1131.
22. Moore MC, Geho WB, Lautz M, Farmer B, Neal DW, and Cherrington AD. Portal serotonin infusion and glucose disposal in conscious dogs. Diabetes 53: 14-20, 2004.
23. Myers SR, Biggers DW, Neal DW, and Cherrington AD. Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. J Clin Invest 88: 158-167, 1991.
24. Niijima A. Afferent impulse discharges from glucoreceptors in the liver of the guinea pig. Ann NY Acad Sci 157: 690-700, 1969.
25. Niijima A. Visceral afferents and metabolic function. Diabetologia 20, Suppl. 325-330, 1981.
26. Nishizawa M, Moore MC, Shiota M, Gustavson SM, Snead WL, Neal DW, and Cherrington AD. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs. Am J Physiol Endocrinol Metab 284: E1027-E1036, 2003.
27. Pagliassotti MJ, Holste LC, Moore MC, Neal DW, and Cherrington AD. Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the dog. J Clin Invest 97: 81-91, 1996.
28. Park S and Choi SB. Does fluoxetine administration influence insulin resistance in 90% pancreatectomized rats? Metabolism 51: 38-43, 2002.
29. Pussard E, Guigueno N, Adam O, and Giudicelli JF. Validation of HPLC-amperometric detection to measure serotonin in plasma, platelets, whole blood, and urine. Clin Chem 42: 1086-1091, 1996.
30. Rattigan S, Dora KA, Colquhoun EQ, and Clark MG. Serotonin-mediated acute insulin resistance in the perfused rat hindlimb but not in incubated muscle: a role for the vascular system. Life Sci 53: 1545-1555, 1993.
31. Satake S, Moore MC, Igawa K, Converse M, Farmer B, Neal DW, and Cherrington AD. Direct and indirect effects of insulin on glucose uptake and storage by the liver. Diabetes 51: 1663-1671, 2002.
32. Steele R, Wall JS, DeBodo RC, and Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15-24, 1956.
33. Sussman N, Ginsberg DL, and Bikoff J. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials. J Clin Psychiatry 62: 256-260, 2001.
34. Tatsumi M, Groshan K, Blakely RD, and Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340: 249-258, 1997.
35. United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998.
36. Van Harten J. Overview of the pharmacokinetics of fluvoxamine. Clin Pharmacokinet 29: 1-9, 1995.
37. Wieczorek I, Schulz C, Jarry H, and Lehnert H. The effects of the selective serotonin reuptake-inhibitor fluvoxamine on body weight in Zucker rats are mediated by corticotropin-releasing hormone. Int J Obes Relat Metab Disord 25: 1566-1569, 2001.
38. Yamada J, Sugimoto Y, and Inoue K. Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms. Eur J Pharmacol 382: 2111-2215, 1999.